Rare low-grade pediatric-type astrocytoma with MYB/MYBL1 alteration. A case report and literature review
- 3 April 2026
- journal article
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 13 (1)
Abstract
Diffuse astrocytoma with MYB or MYBL1 alteration is a newly defined molecular subtype of pediatric-type low-grade diffuse gliomas. This tumor type was first included in the 2021 World Health Organization classification of tumors of the central nervous system. To date, only a limited number of cases with a similar histo-molecular profile have been reported in the literature. The tumor is characterized by a favorable clinical course and prognosis. This report presents a clinical case of a brain astrocytoma with MYB/MYBL1 alteration in a 2-year-old girl. A distinctive feature of this case is the absence of any specific antitumor treatment – the patient did not undergo chemotherapy or radiotherapy. Only stereotactic biopsy was performed, followed by histological and molecular verification of the diagnosis. Eight years after the initial diagnosis, the disease remains stable, with some reduction in tumor size observed over time. According to our data, the presented case of MYB/MYBL1-altered astrocytoma is unique within the Russian medical literature.Keywords
This publication has 11 references indexed in Scilit:
- MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genesActa Neuropathologica, 2024
- LGG-53. RESULTS FROM THE PHASE 1 AND PHASE 1 EXPANSION COHORTS OF SJ901: A PHASE 1/2 TRIAL OF SINGLE-AGENT MIRDAMETINIB (PD-0325901) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOW-GRADE GLIOMANeuro-Oncology, 2024
- Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade gliomaNeuro-Oncology, 2024
- Pediatric low-grade glioma: State-of-the-art and ongoing challengesNeuro-Oncology, 2023
- Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 casesThe Neuroradiology Journal, 2022
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology, 2021
- A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alterationActa Neuropathologica, 2019
- Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseActa Neuropathologica, 2019
- cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutationActa Neuropathologica, 2019
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyActa Neuropathologica, 2016